ML20105A310

Shine Medical Technologies, LLC, Supplement 2 to License Application, Rev. 2 to Final Safety Analysis Report, Chapter 14, Technical Specifications

ML20105A310
Person / Time
Site:	SHINE Medical Technologies
Issue date:	03/27/2020
From:	SHINE Medical Technologies
To:	Office of Nuclear Reactor Regulation
Shared Package
ML20105A242	List: ML20105A243 ML20105A244 ML20105A245 ML20105A246 ML20105A247 ML20105A248 ML20105A249 ML20105A250 ML20105A251 ML20105A252 ML20105A253 ML20105A255 ML20105A256 ML20105A258 ML20105A259 ML20105A260 ML20105A261 ML20105A262 ML20105A263 ML20105A264 ML20105A265 ML20105A267 ML20105A268 ML20105A269 ML20105A270 ML20105A271 ML20105A273 ML20105A275 ML20105A277 ML20105A295 ML20105A296 ML20105A297 ML20105A298 ML20105A299 ML20105A300 ML20105A301 ML20105A302 ML20105A303 ML20105A304 ML20105A305 ML20105A306 ML20105A307 ML20105A308 ML20105A309 ML20105A310 ML20105A311 ML20105A312 ML20105A313 ML20105A314 ML20105A315 ... further results
References
2020-SMT-0025
Download: ML20105A310 (6)

Text

Chapter 14 - Technical Specifications Table of Contents CHAPTER 14 TECHNICAL SPECIFICATIONS TABLE OF CONTENTS Section Title Page 14.1 TECHNICAL SPECIFICATIONS ......................................................................... 14.1-1

14.2 REFERENCES

.................................................................................................... 14.2-1 SHINE Medical Technologies 14-i Rev. 0

Chapter 14 - Technical Specifications List of Tables LIST OF TABLES Number Title None SHINE Medical Technologies 14-ii Rev. 0

Chapter 14 - Technical Specifications List of Figures LIST OF FIGURES Number Title None SHINE Medical Technologies 14-iii Rev. 0

Chapter 14 - Technical Specifications Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition ANS American Nuclear Society ANSI American National Standards Institute SHINE Medical Technologies 14-iv Rev. 0

Chapter 14 - Technical Specifications Technical Specifications CHAPTER 14 - TECHNICAL SPECIFICATIONS 14.1 TECHNICAL SPECIFICATIONS The SHINE technical specifications were developed following the format and content guidance of American National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and incorporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 1996b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2012a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical specifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines.

Observance of these technical specifications limits the likelihood and consequences of malfunctions.

SHINE Medical Technologies 14.1-1 Rev. 0

Chapter 14 - Technical Specifications References

14.2 REFERENCES

ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.

USNRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 27, 2012.

USNRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, October 27, 2012.

SHINE Medical Technologies 14.2-1 Rev. 0